# Vitamin D Serum Status and Associated Factors Among Women with Cervical Lesions

**Authors:** Zinhle Simelane, Likhona S. Masika, Charles B. Businge, Zizipho Z. A. Mbulawa

PMC · DOI: 10.3390/epidemiologia7020040 · 2026-03-04

## TL;DR

This study found that many women with cervical lesions in South Africa have low vitamin D levels, with a link to body mass index.

## Contribution

The study provides new insights into vitamin D status among women with cervical lesions in a high-burden setting.

## Key findings

- Vitamin D insufficiency was observed in 46.60% of participants.
- Deficiency was most common in women with healthy BMI values.
- Vitamin D deficiency or insufficiency was more common than sufficiency.

## Abstract

Background/Objectives: Vitamin D plays a role in cellular regulation and immune processes relevant to cervical carcinogenesis, yet data on vitamin D status and its determinants in high-burden settings such as South Africa remain scarce. This paper therefore describes the prevalence of vitamin D deficiency, insufficiency, and sufficiency, and explores associated factors among women with cervical lesions. Methods: A descriptive cross-sectional study was conducted among 103 women aged 18–81 years. Women were referred to Nelson Mandela Academic Hospital due to cervical cancer, high-grade squamous intraepithelial lesions (HSILs), or atypical squamous cells—cannot exclude HSIL, or low-grade squamous intraepithelial lesions, or atypical squamous cells of undetermined significance. The total serum 25(OH)D (D2 + D3) was quantified using the MAGLUMI 25-OH Vitamin D chemiluminescent immunoassay kit on the MAGLUMI X3 Fully Automatic Chemiluminescence Immunoassay Analyzer (Snibe Diagnostic, Shenzhen New Industries Biomedical Engineering Co., Ltd., Shenzhen, China). Serum vitamin D was categorized according to the Endocrine Society Task Force guidelines. Results: Vitamin D insufficiency was observed in 46.60% of participants and deficiency in 26.21% while only 27.18% had sufficient levels. Overall, vitamin D deficiency or insufficiency was more common than sufficiency (72.82%; 27.18%, p < 0.0001). Among HIV-positive women, 78.26% had vitamin D deficiency or insufficiency compared with 63.33% of HIV-negative women; however, this difference was not statistically significant. Vitamin D deficiency was most prevalent in women with healthy body mass index (BMI, 46.40%) values and decreased significantly with increasing BMI values (p = 0.008). Conclusions: Vitamin D deficiency and insufficiency were common among women with cervical lesions in this rural South African population. Associations with BMI suggest context-specific influences on vitamin D status. Owing to the study’s cross-sectional design and lack of normal cervical cytology participants, the findings are descriptive and exploratory, underscoring the need for longitudinal and comparative research to better define the role of vitamin D in cervical disease.

## Linked entities

- **Diseases:** cervical cancer (MONDO:0002974)

## Full-text entities

- **Genes:** LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, GC (GC vitamin D binding protein) [NCBI Gene 2638] {aka DBP, DBP-maf, DBP/GC, GRD3, Gc-MAF, GcMAF}, DBP (D-box binding PAR bZIP transcription factor) [NCBI Gene 1628] {aka DABP, taxREB302}
- **Diseases:** cervical neoplasia (MESH:D002578), ASC-H (MESH:D065309), cachexia (MESH:D002100), deficiency (MESH:D007153), Cervical cancer (MESH:D002583), insufficiency (MESH:D000309), cervical carcinogenesis (MESH:D063646), obese (MESH:D009765), gynaecological disease (MESH:D004194), invasive cancer (MESH:D009362), HIV (MESH:D015658), genital ulcer (MESH:D014456), HPV infection (MESH:D030361), injury to (MESH:D014947), Vitamin D Deficiency (MESH:D014808), infection (MESH:D007239), HIV infection (MESH:D015490), adiposity (MESH:D018205), inflammation (MESH:D007249), precancerous and malignant lesions (MESH:D011230), HSIL (MESH:D000081483), cancer (MESH:D009369), Weight loss (MESH:D015431), warts (MESH:D014860), Overweight (MESH:D050177), vaginal bleeding (MESH:D014592), Cervical Lesions (MESH:D002575), abnormal cervix (MESH:D002577)
- **Chemicals:** calcitriol (MESH:D002117), alcohol (MESH:D000438), 25(OH)D3 (MESH:C104450), 25(OH)D (-), calcium (MESH:D002118), Vit D (MESH:D014807), melanin (MESH:D008543), 1,25(OH)2D. (MESH:C097949), phosphate (MESH:D010710)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Human papillomavirus (species) [taxon 10566]
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13010710/full.md

---
Source: https://tomesphere.com/paper/PMC13010710